Opportunity overview
Purchase of Xofigo for 2026 - radiopharmaceutical for prostate cancer treatment in Nuclear Medicine.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Bayer Public Limited Company
Matched by exact name
- Contract value
- £105.6k
- Awarded
- Not supplied
- Contract signed
- 31 Dec 2025
- Including VAT
- £126.7k
- Award ID
- 1
- Status
- active
- Location
- Reading, UKJ11, RG2 6AD, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract details notice on Find a TenderOpen source ↗